NCT02382146View on ClinicalTrials.gov

Prevention of Postoperative Nausea and Vomiting

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

dexamethasone ondansetron

dexamethasone 8 mg intravenous ondansetron 4 mg intravenous dimenhydrinate 1mg/kg intravenous

DRUG

Dexamethasone dimenhidrinate

dexamethasone 8 mg intravenous dimenhydrinate 1mg/kg intravenous

Trial Locations (1)

34752

Turkey, Istanbul

All Listed Sponsors
lead

Yeditepe University Hospital

OTHER

NCT02382146 - Prevention of Postoperative Nausea and Vomiting | Biotech Hunter | Biotech Hunter